每周股票复盘：振德医疗（603301）Q2净利降12.76%

Core Viewpoint - ZhenDe Medical's stock price has shown a slight decline, with a current market capitalization of 6.475 billion yuan, ranking 55th in the medical device sector and 2698th in the A-share market [1] Trading Information Summary - On August 27, ZhenDe Medical recorded a large transaction amounting to 2.32 million yuan [2][7] Shareholder Changes - As of June 30, 2025, the number of shareholders for ZhenDe Medical was 22,600, a decrease of 2,047 or 8.29% from March 31, 2025. The average number of shares held per shareholder increased from 10,800 to 11,800, with an average holding value of 248,400 yuan [3][7] Performance Disclosure Highlights - ZhenDe Medical's mid-year report for 2025 indicated a main revenue of 2.1 billion yuan, a year-on-year increase of 2.83%. However, the net profit attributable to shareholders decreased by 20.7% to 128 million yuan, and the net profit excluding non-recurring items fell by 26.97% to 118 million yuan. In Q2 2025, the main revenue was 1.109 billion yuan, up 2.79% year-on-year, while the net profit attributable to shareholders was 76.52 million yuan, down 12.76% year-on-year [4][7] Company Announcement Summary - ZhenDe Medical will hold a half-year performance briefing on September 11, 2025, from 10:00 to 11:00 at the Shanghai Stock Exchange Roadshow Center. Investors can submit questions from September 4 to September 10, and the company will address commonly asked questions during the meeting [5][7]